Vinod Ganju

6PUBLICATIONS
39CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Linguistic anthropologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 22, 2024
A Novel Designed Anti-PD-L1/OX40 Bispecific Antibody Augments Both Peripheral and Tumor-Associated Immune Responses for Boosting Antitumor Immunity.

Baocun Li, Shiyong Gong, Nianying Zhang

|Jun 20, 2024
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial.

Herui Yao, Min Yan, Zhongsheng Tong

|Nov 17, 2023
Phase I/IIa Trial in Advanced Pancreatic Ductal Adenocarcinoma Treated with Cytotoxic Drug-Packaged, EGFR-Targeted Nanocells and Glycolipid-Packaged Nanocells.

Vinod Ganju, Gavin Marx, Scott Pattison

|Jun 30, 2022
Reply to F. Keane et al.

Vinod Ganju, Daniel Croagh, Joanne Lundy

|Oct 22, 2021
Lineage-restricted neoplasia driven by Myc defaults to small cell lung cancer when combined with loss of p53 and Rb in the airway epithelium.

Jasmine Chen, Aleks Guanizo, Quinton Luong

|Oct 24, 2018
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer.

Tracy L Leong, Velimir Gayevskiy, Daniel P Steinfort

Pageof 1

Frequent Collaborators

1 joint publications

Marc R De Massy

1 joint publications

Fernando J Rossello

1 joint publications

Marie-Liesse Asselin-Labat

1 joint publications

Jason E Cain